Detalles de la búsqueda
1.
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutations.
Oncologist
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38885246
2.
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.
Br J Cancer
; 116(7): 874-883, 2017 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28222071
3.
A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination.
Prostate
; 75(14): 1518-25, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26012728
4.
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.
Oncologist
; 18(2): 163-73, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23340005
5.
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
; 27(6): 1623-1630, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451978
6.
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.
Clin Cancer Res
; 24(2): 306-315, 2018 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29113986
7.
A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.
Cancer Prev Res (Phila)
; 6(10): 1120-7, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23985577
8.
A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone.
Cancer Chemother Pharmacol
; 67(2): 431-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20445979
9.
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors.
J Clin Oncol
; 26(12): 1940-7, 2008 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18421048
Resultados
1 -
9
de 9
1
Próxima >
>>